“…These factors include immunosuppression and a dysregulated inflammatory response secondary to malignant bone marrow infiltration and chronic glucocorticoid use, infection from long-term indwelling central venous catheters, and acute and chronic organ toxicity from chemotherapy agents (7). Additionally, patients who undergo hematopoietic cell transplant (HCT) are subject to unique complications such as graft-versus-host disease, idiopathic pneumonia syndrome, diffuse alveolar hemorrhage, and sinusoidal obstruction syndrome, which further increases critical care utilization, intensive care unit (ICU) morbidity, and mortality in these patients (7)(8)(9)(10)(11)(12). Furthermore, post-HCT patients and those with underlying malignancies who require critical care have higher rates of resource utilization, such as invasive mechanical ventilation, vasoactive infusions, and continuous renal replacement therapy, as well as higher mortality, when compared to the general inpatient pediatric population (6).…”